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The thesis advanced in this essay is that stem cells—particularly those in the nervous system—are compo-
nents in a series of inborn ‘programs’ that not only ensure normal development, but persist throughout
life so as to maintain homeostasis in the face of perturbations—both small and great. These programs
encode what has come to be called ‘plasticity’. The stem cell is one of the repositories of this plasticity.
This review examines the evidence that interaction between the neural stem cell (as a prototypical somatic
stem cell) and the developing or injured brain is a dynamic, complex, ongoing reciprocal set of interactions
where both entities are constantly in flux. We suggest that this interaction can be viewed almost from a
‘systems biology’ vantage point. We further advance the notion that clones of exogenous stem cells in
transplantation paradigms may not only be viewed for their therapeutic potential, but also as biological
tools for ‘interrogating’ the normal or abnormal central nervous system environment, indicating what
salient cues (among the many present) are actually guiding the expression of these ‘programs’; in other
words, using the stem cell as a ‘reporter cell’. Based on this type of analysis, we suggest some of the
relevant molecular pathways responsible for this ‘cross-talk’ which, in turn, lead to proliferation, migration,
cell genesis, trophic support, protection, guidance, detoxification, rescue, etc. This type of developmental
insight, we propose, is required for the development of therapeutic strategies for neurodegenerative disease
and other nervous system afflictions in humans. Understanding the relevant molecular pathways of stem
cell repair phenotype should be a priority, in our view, for the entire stem cell field.
Keywords: degeneration; neural stem cells; regeneration; tissue engineering; inflammation;
transplantation
1. NSCs: THE PROTOTYPICAL SOMATIC STEM
CELL
In thinking about the practical application of stem cell
biology to clinical situations—particularly for the CNS—
it is instructive to remember that study of the NSC—a
prototype for somatic stem cells in general—emerged as
the unanticipated by-product of investigations by develop-
mental neurobiologists into fundamental aspects of neural
determination, commitment and plasticity. Stem cell
behaviour is ultimately an expression of developmental
principles, an alluring vestige from the more plastic and
generative stages of organogenesis. In attempting to apply
stem cell biology therapeutically, it is instructive always to
bear in mind what role the stem cell plays in development
and to what cues it was ‘designed’ to respond in trying
*Author for correspondence (esnyder@burnham.org).
One contribution of 13 to a Discussion Meeting Issue ‘New directions in
tissue repair and regeneration’.
Phil. Trans. R. Soc. Lond. B (2004) 359, 823–837 823  2004 The Royal Society
DOI 10.1098/rstb.2004.1474
to understand the ‘logic’ behind its behaviour (both what
investigators or clinicians want to see and what they do
not want to see). Furthermore, in transplantation para-
digms, the interaction between engrafted NSCs and
recipient host is a dynamic, complex, ongoing reciprocal
interaction where both entities are constantly in flux.
Almost two decades ago, a handful of investigators
interested in fundamental neural development began to
identify, within cultures obtained from the developing and
mature CNS, cells with surprising plasticity, multipotency
and a propensity for dynamically shifting their fates (Ryder
et al. 1990; Reynolds & Weiss 1992; Snyder et al. 1992).
The existence of such cells—if indeed they represented a
population normally resident in the brain—challenged the
prevailing dogma that the nervous system was rigidly and
immutably constructed. ‘NSCs’, as these plastic cells
came to be termed, began to garner the interest of not just
the developmental community but also that of the neural
repair, gene therapy and transplant communities when it
was recognized that they could be expanded in culture and
reimplanted into the mammalian brain where they would
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reintegrate appropriately and stably express foreign genes
(Snyder et al. 1992). Their abundance, multipotency, ease
of manipulation and engraftability made this strategy an
attractive alternative for CNS gene therapy and repair.
Compared with extant techniques, NSCs presented cer-
tain advantages: they were a homogeneous and relatively
well-defined neural cell population that could be easily
stored and expanded on demand, and, if necessary, gen-
etically manipulated ex vivo to express a wide variety of
foreign transgenes. These transduced genes, as well as
their inherent genetic repertoire, could be effectively
imported into the CNS ‘Trojan Horse’-style after trans-
plantation almost anywhere into the developing and
mature host brain. Furthermore, NSCs and their progeny
possessed a capacity to integrate not only locally at their
site of implantation, competing with and interdigitating
seamlessly with endogenous cells (Snyder et al. 1992,
1997; Park et al. 1999; Rosario et al. 1997; Auerbach et
al. 2000; Zlomanczuk et al. 2002), but also more broadly
(Snyder et al. 1995; Ourednik et al. 1999; Yandava et al.
1999; Park et al. 2002). They were quite migratory—parti-
cularly if implanted into germinal zones—allowing cell and
gene therapy to be contemplated for disseminated, even
global, CNS disease processes. In that sense, NSCs had a
distinct advantage over transplanted foetal tissue and non-
neural cells for cell replacement and over most viral vec-
tors and protein infusion devices for gene delivery. Even
such alternative cellular vectors as haematopoietic cells,
when used for protein delivery in bone marrow transplan-
tation paradigms, could not efficiently circumvent the
restrictions of the blood–brain barrier and integrate
throughout the CNS as effectively as NSCs. A single bona
fide NSC clone could take up residence in, and accommo-
date to, any nervous system region, allowing an economy
of resources. In addition, NSCs were attracted by degen-
erating neural tissue (Flax et al. 1998; Park et al. 1999;
Aboody et al. 2000), effectively replacing dead or dysfunc-
tional cells in those regions. In these pathological niches,
these multipotent cells, in response to signals still poorly
understood (though probably linked to inflammatory cyto-
kines as well as to neurotrophic factors), would shift their
progeny’s fate towards that of those neural lineages most
in need of repletion; even if beyond the classical develop-
mental window for genesis of that cell type. Indeed, these
observations gave birth to the hypothesis that certain
neurodegenerative environments recapitulate develop-
mental cues because NSCs responded to neurogenic sig-
nals not only during their normal embryological
expression, but also when recreated by particular types of
cell death. NSCs, in other words, were sufficiently sensi-
tive to ‘sense’ niches of neurogenesis and/or small niduses
of pathology in the brain (Rosario et al. 1997; Snyder et
al. 1997; Flax et al. 1998; Yandava et al. 1999).
In this essay, we will attempt to offer a ‘logic’ for various
stem cell behaviours that are rooted in developmental pro-
cesses. In introducing such concepts, we hope to provide
a framework for viewing, in a cohesive manner, findings
(by us and by others) that might otherwise seem disparate.
2. STEM CELLS AS COMPONENTS IN A SERIES OF
DEVELOPMENTAL ‘PROGRAMS’
Central to the views espoused in this essay is the belief
that we may more intelligently promote neural
Phil. Trans. R. Soc. Lond. B (2004)
stem/progenitor cell compensation in adulthood by first
examining perturbations to the developing, less mature
nervous system so as to discern the mechanisms by which
the CNS shifts developmental patterns to maintain homeo-
stasis. Those mechanisms are probably the key ones to be
‘recapitulated’ in adulthood. In fact, there is likely to be
a continuum between the response of the injured CNS in
adulthood and that in the paediatric age group. For sceptics
of this view, it is important to recognize that, once beyond
foetal life, the temporal ‘windows’ and spatial regions for
neurogenesis are not significantly different in the paediatric
brain than in the adult brain, but the response to pertur-
bations (e.g. injury) appears to be more robust. We can
learn from understanding what constitutive, homeostasis-
preserving developmental ‘programs’ are inherently in place to
deal with perturbations. Indeed, such an understanding
may even explain the degree of spontaneous recovery that
is often, yet inexplicably, seen in adults.
There exist, we believe, intrinsic ‘developmental pro-
grams’ that constitutively unfold throughout life that are
‘designed’ to respond to the exigencies of survival, and
that integrate and coordinate with non-neural as well as
other neural systems. The NSC, we believe, is a mediator
of, and a repository for, this inherent plasticity.
We have somewhat arbitrarily delineated three categories
of program. The first classification we call ‘Macro Pro-
grams’. In such programs, NSCs that emanate from pri-
mary germinal zones participate in organogenesis.
However, in our view, organogenesis entails not only ‘put-
ting the nervous system together’, i.e. creating the struc-
tures, regions and cytoarchitectonics of the brain, but also
establishing ‘reservoirs’ for maintaining homeostasis
throughout life. These reservoirs are typically secondary
germinal zones that persist throughout life.
The second category of programs we call ‘System Pro-
grams’, i.e. programs that constitutively unfold and allow
the structure (or indeed the entire organism) to respond
to perturbations. Such perturbations may be those that
occur during the remainder of the complex yet precise
process of development, or the ‘minor’ perturbations that
occur ‘day-to-day’ throughout the lifespan of an organism
in the ‘wild’, or the ‘extreme’ perturbations that often are
encountered (e.g. ischaemia, trauma, toxins). Compen-
sation for the last perturbations is often insufficient to re-
attain baseline, leaving the organism with a persistent
handicap. Failure of these programs to respond to the
more routine perturbations of daily life may also be the
essence of some slowly progressive degenerative neuro-
pathological processes. The ‘system’ invoked by some pro-
grams may entail the mobilization of stem cells from
secondary germinal zones and the redistribution (in time
and/or space) of the expression of molecular cues.
The third class of programs we term ‘Micro Programs’.
These are programs that direct the process by which cell
type and functional diversity spontaneously emerge within
a given region of the CNS. Some of these programs appear
to allow the multiple progeny of a single stem cell to self-
assemble in an autonomous manner, spontaneously allo-
cating various neural cell type identities to these progeny
such that they interweave with each other to form the ‘fab-
ric’ of a given region of nervous system.
We suggest that a better understanding of these funda-
mental developmental ‘programs’ will ultimately yield not
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only a better understanding of development but also how
best to exploit stem cell biology for therapy. For example,
it might lend insight into the previously unclear teleology
of ‘secondary’ germinal zones and ‘vestigial’ stem cells in
the ‘post-developmental’ or adult CNS. It may also pin-
point and elucidate those developmentally programmed
compensatory mechanisms that need to be re-invoked
and/or exploited for purposes of repair.
Interestingly, the exploration of some of these funda-
mental processes may actually be abetted by the use of
exogenous NSCs—not simply as therapeutic vehicles—
though their utility in that regard will become obvious—
but as biological ‘tools’. In other words, we will introduce
the notion of the NSC as a ‘reporter cell’—by way of anal-
ogy, at the cellular level, to a reporter gene as used in
molecular biology—to reflect (or signal) when a particular
process has occurred. Such exogenous stem cells can
‘interrogate’ the environment and track (i.e. ‘report on’)
the behaviour of endogenous CNS progenitor/stem cells
that are otherwise ‘invisible’ to such monitoring, too few
to track reliably, and whose clonal relationships and
degree of homogeneity may be less certain.
3. ‘MACRO’ PROGRAMS
Recently we observed that, early in embryogenesis, even
in primates, a developmental neurogenic program consti-
tutively allocates the progeny of a single NSC to either par-
ticipate in organogenesis (pool no. 1) or to constitute
secondary germinal zones, the type that persist into adult-
hood (pool no. 2) (Ourednik et al. 2001; figure 1). We
determined this by exploring the process by which the pro-
geny of a single clone of hNSCs became segregated during
cerebrogenesis. A traceable clone of hNSCs was implanted
into the ventricular zone (a primary germinal zone) of foetal
Old World monkeys. Presumably reflecting prevalent mor-
phogenetic programs, the NSCs self-distributed into two
subpopulations: one contributed to corticogenesis by
migrating along radial glia towards the cortical plate, termi-
nating at temporally appropriate layers, and differentiating
into lamina-appropriate neurons or glia; the other subpop-
ulation remained undifferentiated and contributed to a sec-
ondary germinal zone (the subventricular zone) with
occasional members interspersed throughout brain paren-
chyma. These findings suggested the existence of a unitary
embryonic neurogenetic program allocating the progeny of
NSCs either for immediate use in organogenesis or to
quiescent pools for later use in the ‘post-developmental’
(including adult) brain for maintaining homeostasis and/or
subserving self-repair. If true, then the prediction would be
that, in the face of a perturbation, without specific instruc-
tion, induction or non-physiological manipulations, this
developmental pattern (and the secondary stem/progenitor
cell pool that constitutes it) should shift constitutively in
the face of a disequilibrating force towards an attempted
re-establishment of equipoise. Although this remains to be
proven, we have preliminary evidence that suggests the
presence of such ‘System Programs’, as described in § 4.
4. ‘SYSTEM’ PROGRAMS
To test the hypothesis posed in § 3, in pilot studies we
tracked the response of a seemingly hard-wired mammalian
Phil. Trans. R. Soc. Lond. B (2004)
program to extreme perturbations in the mammalian fore-
brain. The program chosen for study was the well-charac-
terized prototypical developmental program known as the
SVZa–RMS–OB axis. In this program, in the intact brain,
endogenous neural progenitors within the SVZa seem to be
invariantly fated throughout life to become interneurons in
the OB. Just as such programs are established to replenish
regions of neuronal turnover (such as the OB), we proposed
that predictable shifts in these patterns (to compensate for
perturbations to other regions of the brain) themselves con-
stitute inborn programs; programs by which a system self-
adjusts. We call these ‘system’ programs.
This SVZa–RMS–OB developmental pattern was exam-
ined after confrontation with a pathological process that
is common and devastating to the paediatric population:
HI brain injury, a major cause of cerebral palsy. Exper-
imentally, unilateral HI injury is produced by ligation of
one of the carotid arteries followed by hypoxia. To trace
the brain’s intrinsic response to this focal injury, experi-
mental mice, at the instant of asphyxiation, were treated
in two ways. First, they were pulsed with BrdU to label
proliferative progenitors. Second, their lateral cerebral
ventricles were injected with a retroviral vector transdu-
cing the lacZ reporter gene that would selectively mark
SVZa cells transiting through the S phase. In these pre-
liminary studies, we indeed observed that this ostensibly
stereotypical, rigid program shifted to maintain homeo-
stasis within the brain. SVZa progenitors were redirected
from supplying the OB to instead attempting to reconsti-
tute regions that had lost cells to asphyxia. The cell types
lost after HI are of all neural lineages, although neurons
and oligodendrocytes are particularly vulnerable.
Although the mammalian cortex is classically considered
a region to which neurons can no longer be added (i.e. a
‘non-neurogenic’ region), new neurons were indeed sup-
plied by the spontaneous redirection of this developmental
program; so, too, were new oligodendrocytes, astrocytes
and even immature, undifferentiated progenitors. The
new neurons were integrated as interneurons—receiving
synaptic input, becoming appropriately activated.
Intriguingly, although this type of injury is traditionally
viewed as ‘focal’, it appeared to change the terrain of the
entire cerebrum: SVZa progenitors on the opposite ‘intact’
side of the brain were also directed away from their
respective OB and instead migrated across the midline to
the injured side. In other words, developmental programs
even on the contralateral side were similarly altered. The
transiently diffuse upregulation of nestin expression
throughout the cerebrum in response to this focal insult
further supported the view that an injured brain changes
in a global manner.
Briefly, programs established during the earliest stage of
development and persisting into the ‘post-developmental
epochs’ are spontaneously redirected to re-establish equi-
poise, this change itself constituting a ‘program’.
Molecules employed in the establishment and mainte-
nance of such patterns in embryogenesis are involved in
these switches. For example, slit-2 is a chemorepulsive
molecule that is believed to play a role in establishing and
maintaining the SVZa–RMS–OB axis by propelling pro-
genitors from the SVZa towards the OB. After HI injury,
however, the typical pattern of slit expression, preliminary
data suggest, dissipates and is redistributed so that it no
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Figure 1. Segregation of the fates of hNSCs and their progeny into two subpopulations after implantation into the ventricular
zones (VZ) of developing Old World monkey brains (modified from Ourednik et al. 2001). Schematics (left) and
photomicrographs (right) illustrating the cells. Coronal sections from representative levels throughout the telencephelon are
illustrated on the left. hNSCs (pre-labelled with BrdU and implanted) dispersed throughout the ventricular system and
integrated into the VZ. From there, clonally related hNSC-derived cells pursued one of two fates, as shown by
immunocytochemical analysis (b–j ). Those donor cells that migrated outwards from the VZ along radial glial fibres into the
developing neocortex constituted one pool or subpopulation. The differentiated phenotype of cells in this subpopulation 1 (red
stars in the schematic) (particularly in layers (II/III) are pictured in (b–h). (b) A human NSC-derived (black nucleus, arrow),
probably according to its size, morphology, large nucleus and location, is visualized (under Nomarski optics) intermingled with
the monkey’s own similar neurons (arrowheads) in neocortical layers II/III. The neuronal identity of such donor-derived cells is
confirmed in (c–e). (c,d, f–h) High-power photomicrographs of human donor-derived cells integrated into the monkey cortex
double-stained with antibodies against BrdU and cell-type-specific markers: (c) NeuN and (d) calbindin for neurons (arrows:
donor-derived cells; arrowheads: host-derived cells); ( f ) CNPase for oligodendroglia (arrow: BrdU black nucleus in CNPase
brown cell; arrowhead indicates long process emanating from the soma); (g,h) GFAP for astroglia (anti-BrdU via fluorescein in
(g); anti-GFAP via Texas Red in (h)). The human-origin of the cortical neurons is further independently confirmed in (e) where
the human-specific nuclear marker NuMA (black nucleus) is co-localized in the same cell with neurofilament (NF)
immunoreactivity (brown). Progeny from this same hNSC clone were also allocated to a second cellular pool—subpopulation 2;
blue dots in the schematic and pictured in ((i, j) arrows)—that remained mainly confined to the SVZ and stained only for an
immature neural marker (vimentin (brown) co-localized with BrdU (black nucleus) in inset, arrows; arrowhead indicates host
vimentin cell). Some members of subpopulation 2 were identified within the developing neocortex intermixed with
differentiated cells. Panels (g,h) employ immunofluorescence; the other immunostains use a DAB-based colour reaction. The
photomicrographs were taken from different animals as representative of all animals. Abbreviations: ‘ve’, lateral cerebral ventricle;
arrow, BrdU donor-derived cell; arrowhead, BrdU-negative, host-derived cell. Scale bars: 30 m (b–d); 20 m (e–j).
longer directs progenitors to the OB but rather ‘forces’
them instead towards the injured cortex. Similarly, in
other pilot studies, another developmentally regulated
molecule, SDF1-, known as an inflammatory chemokine
but recently determined to be an attractant that helps
establish migratory pathways during cerebrogenesis, is
upregulated within the injured region, drawing SVZ pro-
genitors (which bear receptors to this attractant) to the
region. Activated microglia, the omnipresent first wave of
‘invaders’ in most neurodegenerative processes, also
Phil. Trans. R. Soc. Lond. B (2004)
appear to produce factors that beckon NSCs (surprisingly,
NSCs bear receptors to such ‘non-neural’ ligands). NSCs
also bear receptors to vascular endothelium. When the
blood–brain barrier is breached by insults, endothelium is
typically exposed. NSCs are thus presented with another
‘beacon’ to guide their homing response.
These observations suggesting the presence of intrinsic
systems for maintaining homeostasis may explain the
degree of spontaneous recovery long witnessed in infants
and children who have suffered a stroke. It may also
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Figure 2. Multipotent NSCs acquire a neuronal phenotype in regions of adult neocortex subjected to targeted apoptotic
neuronal degeneration (modified from Snyder et al. (1997)). (a) Schematic of procedure by which pyramidal neurons in layer
II of the adult mouse neocortex are induced to die an apoptotic death by injecting nanospheres into the target region of their
transcallosal projections, allowing them to be retrogradely transported back to their somata, and then energizing them via a
laser illumination such that they promote degeneration of those neurons. NSCs were then implanted into the degenerated
region. (b) NSCs differentiate appropriately into only glia (or remain undifferentiated) in intact adult cortex, where
neurogenesis has normally ceased but gliogenesis persists. However, 15% of engrafted cells (identified by their lacZ expression)
in regions of apoptotic neurodegeneration developed neuronal morphology, resembling pyramidal neurons (PNs) within layer
II/III six weeks after transplantation, at 12 weeks of age (i) and immunocytochemical properties consistent with a neuronal
phenotype (ii–iv). (i) Donor-derived cell (which stains blue after Xgal histochemistry to detect lacZ expression) with pyramidal
neuronal morphology and size (large arrow) under bright field microscopy: apical dendrites (‘d’); with descending axons (‘a’).
These features are readily confirmed by ultrastructural criteria under EM (c), where donor-derived cells are noted to receive
both axo-somatic and axo-dendritic synaptic input. Donor-derived cells in control intact adult cortices had only morphologic,
ultrastructural and immunocytochemical features of glia (astrocytes and oligodendrocytes; not shown here but pictured in
Snyder et al. (1997)). (ii–iv) Immunocytochemical analysis. Donor-derived lacZ-expressing cells (identified by an anti-gal
antibody conjugated to Texas Red) are immunoreactive for NeuN (fluorescein, green), a marker for mature neurons. In (ii),
and at higher magnification in (iii), a gal cell (large arrow) double-labels for NeuN. Other small gal cells with non-
neuronal morphology are NeuN (small arrow). Remaining host neurons (NeuN) are gal (arrowhead). (iv) Donor-
derived neuron (gal, NeuN; large arrow) adjacent to two NeuN donor-derived cells (small arrow). Scale bars: (i,ii)
25 m; (iii,iv) 10 m. (c) Ultrastructure of donor-derived neurons in regions of adult cortex subjected to targeted apoptotic
neuronal degeneration. Donor-derived neurons were restricted to the cortex within the degenerated region of layers II/III. In
all panels, Xgal precipitate (‘p’) is visible in the nuclear membrane, cytoplasmic organelles and processes. (i) EM characteristic
suggestive of layer II/III pyramidal neurons are present six weeks after transplantation at 12 weeks of age: large somata (20–
30 m); large nuclei (‘Nu’), prominent nucleoli (‘n’), abundant endoplasmic reticulum and mitochondria (‘m’) and apical
dendrites (‘d’). An afferent synapse is indicated on the donor-derived neuron in (i) (box ‘c’, expanded in (ii)). (ii) Higher
magnification of the axosomatic synapse boxed in (i): presynaptic vesicles (white arrows) and postsynaptic specialization (large
arrow); the postsynaptic region is in continuity with the donor cell nucleus via uninterrupted cytoplasm. Both the cytoplasm
and the nuclear membrane contain precipitate (‘p’). (iii) Axodendritic synapse on the dendrite of a donor-derived neuron:
crystalline, linear Xgal precipitate (‘p’) in the postsynaptic region of the dendrite confirms its donor origin; postsynaptic
specialization with a hazy, nonlinear, non-crystalline appearance immediately under the membrane (large arrows); presynaptic
vesicles clustered near the synaptic densities (small arrows). (iv) Microtubules (arrows, ‘mt’) of 20–26 nm diameter (outlined
by arrowheads) in a donor-derived neuron near precipitate (‘p’) in the nuclear membrane. Scale bars: (i) 1 m; (ii) 200 nm;
(iii) 40 nm; (iv) 500 nm.
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provide a handle for exploiting that response beyond
childhood. Although, in the most devastating cases, this
self-repair mechanism is typically insufficient, the pres-
ence of this altered niche suggests that these responses
might be augmented. To achieve such augmentation, as
well as to better understand this process, in another series
of pilot studies we implanted exogenous ‘reporter’ NSCs
into animals subjected to HI. The insights derived from
these experiments are described in the following sections.
5. CONCEPT OF A ‘REPORTER CELL’ TO
‘INTERROGATE’ THE ENVIRONMENT
Although the cortex is classically deemed to be a ‘non-
neurogenic’ region, the findings above, as well as our past
studies (Snyder et al. 1997; Park et al. 2002) and those of
others (Magavi et al. 2000; Arvidsson et al. 2002), suggest
that conclusions derived from the intact cortex may not
accurately reflect the milieu of the abnormal, injured or
degenerating cortex; that neurodegeneration might convert
the ‘non-neurogenic’ cortex into a ‘neurogenic’ niche from
the ‘viewpoint’ of the NSC in certain areas, and at certain
times, through the recrudescence of signals not normally
seen (or the elimination of restrictive factors/barriers that
normally emerge). Indeed, it was the observation that
exogenous multipotent NSCs could respond to the pre-
vailing cues of normal and abnormal microenvironments
that first suggested the existence of spontaneous com-
pensatory mechanisms for genetic (Snyder et al. 1995;
Rosario et al. 1997; Flax et al. 1998; Park et al. 2002) or
acquired deficiencies (Snyder et al. 1997; Park et al. 1999)
including neurogenesis beyond its normal confines under
certain circumstances.
Several years ago, we and our collaborators first observed
that such a phenomenon might take place in the adult neo-
cortex (figure 2). When a clone of murine NSCs was
implanted into an adult mouse neocortex in which pyrami-
dal neurons of a circumscribed region were induced exper-
imentally to undergo apoptosis, 15% of the transplanted
NSCs ‘altered’ the differentiation path that they would
have otherwise taken. Instead, they differentiated specifi-
cally into pyramidal neurons despite the fact that the ‘nor-
mal’ developmental window for cortical neurogenesis had
long since passed. In intact neocortices, these same NSCs
yielded exclusively glia. Such results suggested that the
‘probe’ that can best ‘interrogate’ the CNS and reflect prevailing
developmental processes is likely to be the NSC itself. NSCs
can mirror subtle changes quite sensitively. Indeed, in the
experiment just described, NSCs could detect the presence
of a small niche—only 3600 m in diameter—of neurogen-
esis by yielding neurons there, and only there. In cortical
regions beyond the perimeter of that circumscribed area of
apoptosis, NSCs, although robustly engrafted, yielded only
non-neurons. Furthermore, the same clone placed in a
given region of the intact brain at different developmental
stages could similarly detect the shift of developmental pro-
grams; for example, in the cortex from a neurogenic region
when implanted prenatally to a non-neurogenic region when
implanted postnatally and, in the cerebellum, from yielding
Purkinje cells prenatally to only small interneurons post-
natally (Snyder et al. 1992; Rosario et al. 1997). Subtleties
in neurogenesis can be assayed so sensitively using NSC
clones that we have come to think of them as ‘reporter
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cells’, integrating and screening a panoply of cues to yield
a relevant read-out (e.g. differentiation towards a particular
phenotype). This technique has been useful to other inves-
tigators as well, for example, in hippocampus and OB
(Suhonen et al. 1996), reinforcing the notion that the same
NSC clone that can give rise to neurons as well as glia in
culture will yield neurons in vivo only when placed into
neurogenic niches; never when placed into environments
unsupportive of neurogenesis.
We used exogenous NSCs to test the hypothesis that
injury and degeneration can change the cortex into a
region that does support neurogenesis. The signals mod-
ifying exogenous and endogenous NSC behaviour are
doubtless a complex of various mitogens and chemokines,
trophic and tropic agents, adhesion and extracellular
matrix molecules, chemotactic and angiogenic factors,
some probably elaborated by reactive astrocytes, activated
microglia, inflammatory cells, invading macrophages and
damaged neurons and glia; some with positive, others with
negative actions on NSCs. If the brain’s ‘attempt’ to repair
itself with its own NSCs falls short solely because their
supply is insufficient in number or insufficiently mobil-
ized, then augmenting that population with strategically
placed exogenous NSCs and/or exogenous trophic factors
(perhaps delivered by NSCs) seems feasible. In pilot stud-
ies, such an approach proved useful for NSC-mediated
neuron replacement in the asphyxiated cerebrum (Park et
al. 1999), as detailed below.
6. ENHANCING NEURONAL DIFFERENTIATION
In preliminary studies, when exogenous NSCs are
transplanted into brains of young mice subjected (as
described above) to unilateral HI injury (optimally within
3–7 days), donor-derived cells migrate preferentially to,
and integrate extensively within, the large ischaemic areas
that typically span the injured ipsilateral hemisphere. Even
donor cells implanted in more distant locations (including
the contralateral hemisphere) migrate towards the regions
of HI injury (emulating what endogenous progenitors
appear to do). (Waiting five weeks post-HI yields virtually
no engraftment, suggesting a ‘window’ for this
phenomenon.) A subpopulation of donor NSCs, parti-
cularly in the penumbra, ‘shift’ their differentiation fate
towards neurons (5%) and oligodendrocytes, the neural
cell types typically damaged after asphyxia/stroke although
no neurons and few oligodendrocytes are derived from
NSCs in intact postnatal neocortex. Clearly, as in the tar-
geted apoptosis model described above, novel signals
appear to be transiently elaborated to which NSCs
respond. Because engrafted NSCs continue to express
their lacZ reporter transgene, it appeared feasible that
desired differentiation of both host and donor-derived
cells might be enhanced if donor NSCs were genetically
manipulated ex vivo to (over)express certain bioactive
transgenes, for example, the neuron-inducing factor NT-
3, a neurotrophic factor it expresses at baseline low
amounts. In pilot studies, a subclone of the NSCs was
transduced with a retroviral vector encoding NT-3. The
engineered NSCs produced large amounts of NT-3 in
vitro (Liu et al. 1999; Himes et al. 2001). We determined,
in pilot studies, that both the parent clone and its NT-3-
producing subclone expressed trkC receptors, that these
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Figure 3. The injured brain interacts reciprocally with NSCs to reconstitute lost tissue—evidence from HI injury (modified
from Park et al. 2002). (a) Characterization of NSCs in vitro when seeded on a PGA scaffold. Cells, seen with scanning
electron microscopy at 5 days after seeding, were able to attach to, impregnate and migrate throughout a highly porous PGA
matrix (arrow). The NSCs differentiated primarily into neurons (greater than 90%) that sent out long complex processes that
adhered to, enwrapped and interconnected the PGA fibres. Scale bar: 20 m. (b) Implantation of NSC/PGA complexes into a
region of cavity formation after extensive HI brain injury and necrosis. Supporting the NSCs on the scaffold not only provided
a template and support, but also allowed protracted interaction between the cells and the degenerating environment. (i) Brain
of an untransplanted (‘non-Tx’) mouse subjected to right HI injury with extensive infarction and cavitation of the ipsilateral
right cortex, striatum, thalamus and hippocampus (arrow). Contrast with (ii), the brain of a similarly injured mouse implanted
with an NSC/PGA complex (‘PGANSCs’) (generated in vitro as per (a) into the infarction cavity 7 days after the induction
of HI (arrow) (n = 60). At maturity (age-matched to the animal pictured in (i)), the NSC/scaffold complex appears, in this
whole-mount, to have filled the cavity (arrow) and become incorporated into the infarcted cerebrum. Representative coronal
sections through that region are seen at higher magnification in (iii) and (iv) in which parenchyma appears to have filled in
spaces between the dissolving black polymer fibres (white arrow in (iii)) and, as seen in (iv), even to support
neovascularization by host tissues (blood vessel indicated by closed black arrow in (iv); open arrow in (iv) points to degrading
black polymer fibre). Scale bars: (iii, iv) 100 m. (c) Characterization in vivo of the neural composition of NSC/PGA
complexes within the HI-injured brain. At two weeks after transplantation of the NSC/PGA complex into the infarction cavity,
donor-derived cells showed robust engraftment within the injured region. An intricate network of multiple long, branching
NF (green) processes were present within the NSC/PGA complex and its parenchyma enwrapping the PGA fibres (orange
autofluorescent tube-like structures under a Texas Red filter), adherent to and running along the length of the fibres (arrows),
often interconnecting and bridging the fibres (arrowheads). Those NF processes were of both host and donor derivation. In
other words, not only were donor-derived neural cells present, but also host-derived cells seemed to have entered the
NSC/PGA complex, migrating along and becoming adherent to the PGA matrix. In a reciprocal manner, donor-derived
(lacZ) neurons (NF cells) within the complex appeared to send processes along the PGA fibres out of the matrix into host
parenchyma as seen in (d ). Scale bar: 100 m. (d ) Long-distance neuronal connections extend from the transplanted
NSC/PGA complexes in the HI-injured brain towards presumptive target regions in the intact contralateral hemisphere. By six
weeks after engraftment, donor-derived lacZ cells appeared to extend many exceedingly long complex NF processes along
the length of the disappearing matrix apparently extending into host parenchyma. To confirm the suggestion that long-distance
processes projected from the injured cortex into host parenchyma, a series of tract tracing studies were performed. (i–vi) BDA-
FITC was injected (iii) into the contralateral intact cortex and external capsule (green arrow) at eight weeks after implantation
of the NSC/PGA complex into the infarction cavity (‘NSC/PGA-Tx’). Axonal projections (labelled green with fluorescein
under an FITC filter) are visualized (via the retrograde transport of BDA) leading back to (across the interhemispheric fissure
(‘IHF’) via the corpus callosum (‘cc’)) and emanating from cells in the NSC/PGA complex within the damaged contralateral
cortex and penumbra (seen at progressively higher magnification in (ii) (region indicated by arrow to (iii)) and (i) (region
indicated by arrow and asterisk (∗) in (iii)). In (i), the retrogradely BDA-FITC-labelled perikaryon of a representative neuron
adherent to a dissolving PGA fibre is well visualized. That such cells are neurons of donor derivation is supported by their
triple-labelling (iv–vi) for lacZ (gal)(iv), BDA-FITC (v), and the neuronal marker NF (vi); arrow in (iv–vi), indicates the
same cell in all three panels. Such neuronal clusters were never seen under control conditions—i.e. in untransplanted cases or
when vehicle or even an NSC suspension unsupported by scaffolds was injected into the infarction cavity. Scale bars: (i)
500 m; (iii) 20 m; (iv–vi) 30 m (scale bar in (vi) also applies to (iv) and (v)). (e) Adverse secondary events that typically
follow injury (e.g. monocyte infiltration and astroglial scar formation) are minimized by, and within, the NSC/PGA complex.
(i–iv) Photomicrographs of H&E-stained sections prepared to visualize the degree of monocyte infiltration in relation to the
NSC/PGA complex and the injured cortex three weeks after implantation into the infarction cavity. Monocytes are classically
recognized under H&E as very small cells with small round nuclei and scanty cytoplasm (e.g. inset in (iv), arrowhead).
Although some very localized monocyte infiltration was present immediately surrounding a blood vessel (‘BV’ in (iii), arrow)
that grew into the NSC/PGA complex from the host parenchyma, there was little or no monocyte infiltration either in the
centre of the NSC/PGA complex (ii) or at the interface between the NSC/PGA complex and host cortical penumbra (i)—in
stark contrast to the excessive monocyte infiltration seen in an untransplanted infarct of equal duration, age and extent (iv),
the typical histopathologic picture otherwise seen after HI brain injury (see inset, a higher magnification of the region
indicated by asterisk in (iv); a typical monocyte is indicated by the arrowhead). Whereas neural cells (nuclei of which are seen
in (i–iii)) adhere exuberantly to the many polymer fibres (‘P’ in (i–iii)), monocyte infiltration was minimal compared with that
in (iv). (v,vi) Astroglial scarring (another pathological condition confounding recovery from ischaemic CNS injury) is also
much constrained and diminished after implantation of the NSC/PGA complex. Although GFAP cells (astrocytes) were
among the cell types into which NSCs differentiated when in contact with the PGA fibres, away from the fibres (∗) there was
minimal astroglial presence either of donor or host origin. (v) GFAP immunostaining recognized by a fluorescein-conjugated
secondary antibody (green) is observed. Note little scarring in the regions indicated by an asterisk. Under a Texas Red filter
(vi) (merged with the fluorescein filter image), the tube-like PGA fibres (arrowhead in both panels) become evident (as an
autofluorescent orange) and most of the donor-derived astrocytes (arrows) (yellow because of their dual lacZ and GFAP
immunoreactivity) are seen to be associated with these fibres, again leaving most regions of the infarct (∗) astroglial scar-free
(arrows in (v) and (vi) point to the same cells). Far from creating a barrier to the migration of host- or donor-origin cells or to
the ingrowth/outgrowth of axons of host- or donor-origin neurons (as per (c) and (d )), NSC-derived astrocytes may actually
have helped provide a facilitating bridge. Scale bars: (i) 10 m; (iii–vii) 20 m.
receptors were appropriately tyrosine-phosphorylated in
response to exogenous NT-3, that this phosphorylation
could be blocked by K252a, and that the signal was
appropriately transduced via MAP kinase. Therefore, it
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appeared that this engineered NSC subclone could not only
secrete excess NT-3, but could also respond to NT-3 in
an autocrine/paracrine fashion. In culture, NT-3-over-
expressing NSCs, like the parent clone, still differentiate
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Figure 3. (Caption p. 829.)
into neurons, astrocytes and oligodendrocytes. However,
unlike the parent clone whose percentage of neurons falls
as new cells are born, the percentage of this NT-3-overex-
pressing subclone that remained neuronal in vitro was ca.
95%. Therefore, pilot studies were performed in which
NT-3-overexpressing NSCs were implanted into the
infarct. NT-3 expression remained robust in vivo. The per-
centage of donor-derived neurons was increased from 5%
(in the above-described pilot experiments) to 20% in the
infarct and to more than 80% in the penumbra. Many of
the neurons became cholinergic, glutamatergic or GABA-
ergic. NT-3 was also probably acting on host as well as
donor cells in a paracrine fashion to enhance their neuronal
differentiation. It is quite plausible that the original yield of
5% new neurons is actually the correct ratio and that 80%
neurons is actually a prescription for dysfunction. Indeed,
we have come to adopt the aphorism that even the ‘dumb-
est stem cell is smarter than the smartest neurobiologist’.
However, the NT-3 experiment serves as a proof-of-con-
cept: the observations suggest that, when a molecular
mechanism underlying a naturally occurring NSC-based
process in a degenerative environment is known, it can be
augmented via genetic engineering. It also enunciated the
potential use of migratory NSCs for simultaneous gene
therapy and cell replacement during the same procedure in
the same recipient using the same cells, an intriguing NSC
ability. This work constitutes a paradigm for using NSCs
to express other trophic factors in other instances, such as
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spinal cord injury. Indeed, we have evidence that the same
parent NSC clone can be variously engineered to express
a range of gene products serving a variety of therapeutic
ends, including NT-4/5, GDNF, BDNF, NGF, L1, sonic
hedgehog, wnt-1, wnt-3a as well as a variety of biosynthetic
and metabolic enzymes. Hence, implantation of genetically
engineered NSCs expressing bioactive transgenes, when
used in a thoughtful manner, might enhance neuronal dif-
ferentiation, neurite outgrowth and proper connectivity.
7. THE INJURED CNS INTERACTS RECIPROCALLY
WITH NSCs TO RECONSTITUTE LOST TISSUE
Once again, using exogenous NSCs to ‘interrogate’ the
environment and using HI brain injury as a prototype for
insults to the CNS (or other organs) characterized by
extensive tissue loss, we confirmed that a reciprocal
dynamic indeed occurs between NSCs and degenerating
neural tissue. Seeding NSCs onto a biosynthetic scaffold,
which is subsequently implanted into the large infarction
cavities of mouse brains injured by HI, not only provided
a template for bridging extensive cystic lesions and guiding
restructuring, but served to ‘fix’ NSCs in space as well as
to ‘fix’ and prolong the effects of: (i) molecules emanating
from the injured brain; and (ii) molecules emanating from
the NSCs (figure 3). In so doing, we were allowed to
observe, in a manner previously unavailable, the multiple
robust reciprocal interactions that spontaneously ensue
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between NSCs and the extensively damaged brain. NSCs
grew exuberantly into a lattice of neurons and glia, paren-
chymal loss was dramatically reduced, an intricate mesh-
work of many highly arborized neurites of both host- and
donor-derived neurons emerged, and some anatomical
connections were reconstituted. The exogenous NSCs,
nestled within the necrotic host parenchyma, altered the
trajectory and complexity of host cortical neurites promot-
ing their entrance into the matrix. In a reciprocal manner,
tract tracing demonstrated donor-derived neurons
extending processes into host parenchyma as far as the
opposite hemisphere. Of interest was the degree to which
these neurons were capable of seemingly directed, target-
appropriate neurite outgrowth without specific external
instructive guidance cues, induction or genetic manipu-
lation of host brain or donor cells. These NSC/scaffold
complexes, these ‘biobridges’, appeared to unveil and/or
augment a constitutive reparative response by facilitating
a series of reciprocal interactions between NSC and host
CNS tissue (both injured and intact), including promoting
neuronal differentiation, enhancing the ingrowth/
outgrowth of neural processes, fostering the reformation
of cortical tissue and promoting connectivity after brain
injury. Inflammation and scarring were also reduced, facil-
itating reconstitution.
That certain reciprocal interactions spontaneously
unfold between transplanted NSCs and an injured host,
as if ‘pre-programmed’, suggests that NSCs might influ-
ence the fate of host cells as profoundly as the fate of the
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NSC itself is changed. The power and implications of this
under-recognized axis of influence is discussed in § 8.
8. NSCs DISPLAY AN INHERENT MECHANISM FOR
RESCUING DYSFUNCTIONAL NEURONS AND
AXONS
The notion that stem cells, as exemplified by NSCs,
may actually possess an intrinsic capacity to ‘rescue’ dys-
functional host neurons and their connections was first
confirmed in two very different situations: the brains of
aged mice (Ourednik et al. 2002; figure 4) and the injured
spinal cords of adult rats (Teng et al. 2002; figure 5).
One of these studies focused on a neuronal cell type
with stereotypical projections that is commonly compro-
mised in the aged brain—the DA neuron (Ourednik et al.
2002; figure 4). The DA-selective neurotoxin (and com-
plex I inhibitor) MPTP (via its metabolite MPP) was
administered systemically to intensify and accelerate per-
manent impairment of these neurons bilaterally (an
experimental lesion that emulates Parkinson’s disease).
Unilateral implantation of murine NSCs into the mid-
brains of these aged Parkinsonian mice promoted reconsti-
tution of the mesostriatal system, an impressive outcome
supported by both histological and functional assays. The
recovery of DA activity mirrored the spatio-temporal dis-
tribution of donor-derived cells. Although the spon-
taneous conversion of some donor NSCs into replacement
DA neurons contributed to nigral reconstitution in
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Figure 4. NSCs possess an inherent mechanism for rescuing dysfunctional neurons: evidence from the effects of NSCs in the
restoration of mesencephalic DA function (modified from Ourednik et al. 2002). (a) TH expression in mesencephalon and
striatum of aged mice after MPTP lesioning and unilateral NSC engraftment into the SN/VTA. A model that emulates the
slow dysfunction of ageing DA neurons in SN was generated by giving aged mice repeated high doses of MPTP. Schematic
on top indicates the levels of the analysed transverse sections along the rostrocaudal axis of the mouse brain. Representative
coronal sections through the striatum are presented in (i), (iii), (v) and (vii) and through the SN/VTA area in (ii), (iv), (vi)
and (viii). (i,ii) Immunodetection of TH (black cells) shows the normal distribution of DA-producing TH neurons in
coronal sections in the intact SN/VTA (ii) and their projections to the striatum (i). (iii,iv) Within one week, MPTP-treatment
caused extensive and permanent bilateral loss of TH immunoreactivity in both the mesostriatal nuclei (iii) and the striatum
(iv), which lasted throughout life. Shown in this example, and matching the time-point in (vii,viii), is the situation in a mock-
grafted animal four weeks after MPTP-treatment. (v,vi) Unilateral (right side) stereotactic injection of NSCs into the nigra is
associated, within one week after grafting, with substantial recovery of TH synthesis within the ipsilateral DA nuclei (vi) and
their ipsilateral striatal projections (v). By three weeks post-transplant, however (vii,viii), the asymmetric distribution of TH
expression disappeared, giving rise to TH immunoreactivity in the midbrain (viii) and striatum (vii) of both hemispheres that
approached that of intact controls (i,ii) and gave the appearance of mesostriatal restoration. Similar observations were made
when NSCs were injected four weeks after MPTP-treatment (not shown). Scale bars: (i), (iii), (v) and (vii) 2 mm; (ii), (iv),
(vi) and (viii) 1 mm. Note the ectopically placed TH cells in (viii). These are analysed in greater detail, together with the
entire SN, in (b). (b) Immunohistochemical analyses of TH, DAT, and BrdU-positive cells in MPTP-treated and grafted
mouse brains. The presumption was initially that the NSCs had replaced the dysfunctional TH neurons. However,
examination of the reconstituted SN with dual gal (green) and TH (red) ICC showed that (i) 90% of the TH cells in the
SN were host-derived cells that had been rescued and only 10% donor-derived (iv). Most NSC-derived TH cells were
actually just above the SN ectopically (blocked area in (i), enlarged in (ii)). These photomicrographs were taken from
immunostained brain sections from aged mice exposed to MPTP, transplanted one week later with NSCs, and sacrificed after
three weeks. The following combinations of markers were evaluated: TH (red) with gal (green) (i–iv); NeuN (red) with gal
(green) (v); GFAP (red) with gal (green) (vi); CNPase (green) with gal (red) (vii); as well as TH (brown) and BrdU
(black) (xi); GFAP (brown) with BrdU (black) (xii); and CNPase (brown) with BrdU (black) (xiii). Anti-DAT-stained areas
are revealed in green in the SN of intact (viii), mock-grafted (ix), and NSC-grafted (x) brains. Three different fluorescence
filters specific for Alexa Fluor 488 (green), Texas Red (red) and a double-filter for both types of fluorochromes (yellow) were
used to visualize specific antibody binding; (iii,iv), and (viii–x) are single-filter exposures; (i,ii) and (v–vii) are double-filter
exposures. (i) Shows a low-power overview of the SNVTA of both hemispheres, similar to the image in figure 4a(viii). Most
TH cells (red cells in (i)) within the nigra are actually of host origin (ca. 90%) with a much smaller proportion being of
donor derivation (green cells) (ca. 10%) (representative close-up of such a donor-derived TH cell in (iv)). Although a
significant proportion of NSCs did differentiate into TH neurons, many of these actually resided ectopically, dorsal to the
SN—(boxed area in (i), enlarged in (ii); high power view of donor-derived (green) cell that was also TH (red) in (iii))—
where the ratio of donor-to-host cells was inverted: ca. 90% donor-derived compared with ca. 10% host-derived. Note the
almost complete absence of a green gal-specific signal in the SNVTA whereas, ectopically, many of the TH cells were
double-labelled and thus NSC-derived (appearing yellow-orange in higher power under a red/green double-filter in panel (ii)).
(iii–vii) NSC-derived non-TH neurons (NeuN) ((v), arrow), astrocytes (GFAP) (vi) and oligodendrocytes (CNPase)
((vii), arrow) were also seen, both within the mesencephalic nuclei and dorsal to them. (viii–x) The green DAT-specific signal
in (x) suggests that the reconstituted mesencephalic nuclei in the NSC-grafted mice (as in (a(viii)) were functional DA
neurons comparable to those seen in intact nuclei (viii) but not in MPTP-lesioned sham-engrafted controls (ix). This further
suggests that the TH mesostriatal DA neurons affected by MPTP are, indeed, functionally impaired. (Note that sham-
grafted animals (ix), contain only punctate residual DAT staining within their dysfunctional fibres, whereas DAT staining in
normal (viii) and, similarly, in engrafted (x) animals was normally and robustly distributed both within processes and
throughout their cell bodies.) (xi–xiii) Any proliferative BrdU cells after MPTP insult and/or grafting were confined to glial
cells whereas the TH neurons (xi) were BrdU. This finding suggested that the reappearance of TH host cells was not
the result of neurogenesis but rather the recovery of extant host TH neurons. Scale bars: (i) 90 m; (ii–v) 20 m; (vi)
30 m; (vii) 10 m; (viii–x) 20 m; (xi) 25 m; (xii) 10 m; and (xiii) 20 m.
DA-depleted areas, the majority of DA neurons in the
mesostriatal system were actually ‘rescued’ host cells.
Pools of undifferentiated donor NSCs in, and adjacent to,
the mesostriatal nuclei appeared to have mediated this
‘rescue’. That these pools spontaneously expressed such
neuroprotective substances as GDNF provided, in part, a
plausible molecular basis for this phenomenon. This
unexpected and novel observation suggested that host
structures might benefit not only from NSC-derived
replacement of lost neurons but also from the ‘chaperone’
effect of other NSC-derived progeny. This process, domi-
nant in this Parkinson’s disease model, probably
represents a mechanism of NSC action for a range of neu-
rodegenerative disorders (we have already begun to wit-
ness a similar effect in mouse models of amyotrophic
lateral sclerosis) and provides insight into the broader use
of stem cells from and for other organ systems.
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A similar mechanism plays a pivotal and equally unan-
ticipated role in a model of acquired neural impairment,
spinal cord injury (figure 5). Murine NSCs were
implanted into the extensive injury site that results when
the spinal cords of adult rats are subjected to a hemi-resec-
tion between thoracic levels 9 and 10 (T9–10) (Teng et al.
2002). (As described for the extensive cerebral ischaemic
lesions detailed above (Park et al. 2002), these NSCs, too,
were supported by a biodegradable synthetic scaffold to
fix them in space.) Hindlimb deficits were evaluated
weekly for up to a year. By 2–3 months post-implant,
engrafted rats exhibited coordinated weight-bearing
stepping whereas the lesion-control group failed to ambu-
late even months after injury (see Movie 1 www.pnas.org).
Improvement persisted for at least a year (when the study
was terminated). Histology, immunocytochemistry
(including for expression of GAP-43, a marker of
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regeneration) and tract-tracing all suggested that the long-
term reduction in functional deficits resulted not from
replacement of neural fibres by the NSCs, but rather from
their role in providing trophic support, reducing scar for-
mation, increasing the amount of preserved host tissue
(including neuronal) by mitigating secondary cell death,
promoting host fibre regrowth through the lesion epi-
centre, and catalysing regeneration of damaged host
tissue. Indeed, the NSCs themselves remained largely
immature nestin-expressing cells; not differentiating into
neurons but also not becoming astrocytes that might con-
tribute to the glial scar (which, in fact, was significantly
diminished). As noted above for neurodegenerative dis-
eases, it appeared that NSCs in their non-neuronal state,
within the traumatized CNS, also produced growth factors,
anti-inflammatory factors, angiogenic factors and differen-
tiation factors, to a degree not witnessed if they had become
neuronally committed. Indeed, NSCs in this state may be
superior tools for promoting repair in some acquired
conditions (e.g. trauma, ischaemia, toxins)—via their pro-
motion of host axonal regeneration and/or preservation.
Suspecting that NSCs may constitutively express these
factors as part of their fundamental biology, we began to
explore the possibility that their natural production of neur-
otrophic agents (particularly those known to promote sen-
sory and motor axon growth) might be by used
intentionally to promote regeneration. To examine, in vivo,
the effects of NSCs on host axonal regeneration, adult rats
underwent lesions of the cervical (C3) spinal cord with a
microwire knife (Lu et al. 2003). This cervical lesion tran-
sects the dorsal columns bilaterally, thereby disrupting both
descending motor cortico-spinal projections and ascending
dorsal column proprioceptive pathways. Murine NSCs
were injected into the lesion cavity immediately post-lesion.
NSCs survived well in vivo after grafting, filling the lesion
site, becoming well vascularized. Their extension stopped
at the borders of the injury; there was no deformation of
the spinal cord or tumour formation. In this model, the
NSCs remained undifferentiated, labelling for nestin but
not for neuronal, astroglial or oligodendroglial markers.
Despite the absence of NSC differentiation, or possibly
because of it, axons were observed penetrating the grafts
directly from the host stem cell (to a significantly greater
extent than control fibroblasts grafts). Furthermore, spe-
cific classes of host axons grew extensively within the grafts:
motor axons labelled with choline acetyl transferase
(ChAT), and sensory axons labelled with calcitonin gene-
related peptide (CGRP) or p75. These findings further sug-
gested that NSCs can inherently provide permissive sub-
strates and factors to promote growth of host axons in vivo.
Indeed, attempting to intervene in the natural expression of
the various neurotrophic factors in their various proportions
through genetic manipulation actually appeared to throw
the system into somewhat of an imbalance (Lu et al. 2003).
For example, in the above-described experiments, enhanc-
ing expression of NT-3 in a given clone of NSCs actually
extinguished its expression of GDNF, obliterating its pro-
motion of motor axonal ingrowth, which instead became
supplanted by the enhanced ingrowth of sensory axons. In
other words, manipulating one aspect of a delicately bal-
anced natural system may yield desirable effects if the
consequences are understood, but may also yield
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unanticipated and undesirable effects if the system and its
‘logic’ from the ‘viewpoint’ of the NSC are not.
The molecular mechanism underlying all of these
above-described observations, we believe, constitutes the
normal constitutive expression of yet another developmen-
tal program—one we term a ‘Micro Program’—and is dis-
cussed in § 9.
9. RECIPROCAL SIGNALLING: EXPRESSION OF
DEVELOPMENTAL ‘MICRO’ PROGRAMS
In preliminary studies, it was determined via enzyme-
linked immunosorbent assay (ELISA), Western blots and
immunocytochemistry that murine and human NSCs
constitutively produce a broad range of peptide neuro-
trophic and neurite outgrowth-promoting factors that
function appropriately in appropriate bioassays (e.g. the
promotion of motor neuron outgrowth from organotypic
spinal explants). Conditioned medium from NSCs
contained significant quantities of NGF (7.5 ± 2.5 pg per
106 cells per day), BDNF (7.1 ± 0.1 pg per 106 cells per
day), GDNF (70 ± 1 pg per 106 cells per day) (Lu et al.
2003), and others. Fibroblasts expressed no detectable
levels. Out of the various factors, GDNF was of particular
interest because of its known neuroprotective and out-
growth-promoting effect on such ventralized neural cell
types as nigral DA neurons and spinal anterior horn motor
neurons—cell types we had established to be impacted in
vivo by NSCs (Ourednik et al. 2002; Teng et al. 2002; Lu
et al. 2003). We elected, in preliminary studies, to use
GDNF as an index neurotrophic agent and explore the
NSC’s regulation of its intrinsic GDNF expression to help
reveal what we believed was a little recognized but pervasive
NSC developmental mechanism with powerful therapeutic
possibilities. In pilot studies, using motor neuron axon out-
growth from spinal explants as a quantifiable bioassay, it
was determined that NSCs could mimic the effect of
exogenously administered GDNF peptide; GDNF anti-
sense or a soluble ‘scavenger’ GDNF receptor was suf-
ficient to blunt NSC-induced neurite outgrowth whereas
stem cell explants obtained from the ret (GDNF-receptor)-
null mouse, when used in this bioassay, elaborated dramati-
cally fewer axons towards the NSCs. Of interest was the
observation that, when the progeny of a given NSC clone
existed in a non-neuronal (undifferentiated or glial) state,
intrinsic GDNF expression was robust. Curiously, how-
ever, the cell in that state could not respond to the GDNF
it had just produced because it did bear a GDNF (ret)
receptor. By contrast, when the same clonal progeny was
induced to differentiate into neurons, GDNF production
diminished virtually to nil, but gave way to expression of
a functional ret-receptor, one that could be appropriately
phosphorylated by GDNF. This dynamic suggested a
developmental program—a ‘micro’ program, if you will—
by which a single ‘mother’ NSC gives rise to progeny that,
in a symbiotic fashion, provide reciprocal support for each
other; serving as ‘chaperones’.
Using subclones of NSCs that contained various neural
cell-type-specific promoters driving green fluorescent protein
expression to signal when various fate decisions were made
by various equipotent members of a given clone, we began to
amass preliminary evidence that pointed to an ‘autonomous
CNS self-assembly program’ pursued constitutively by
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Figure 5. Functional recovery after traumatic spinal cord
injury mediated by a unique polymer scaffold seeded with
NSCs (modified from Teng et al. 2002). (a) Schematics of
scaffold design showing inner and outer portions. (i,ii) Inner
scaffold seeded with NSCs. Outer scaffold created to have
long, axially oriented pores for axonal guidance and radial
pores to allow fluid transport and inhibit ingrowth of cells.
(iv) Schematic of surgical insertion of implant into SC. (b)
Based on BBB open-field walking scores, the
‘scaffoldNSCs’ group showed significant improvement in
open-field locomotion compared with ‘lesion-control’ groups
(p 0.007). Histology (H&E) of longitudinal sections from
(i) lesioned untreated group and from (ii) ‘scaffoldcells’
groups was revealing. Note greater integrity of parenchyma
in the latter. (c) Examination of composition of the tissue at
the lesion site demonstrated numerous NF cells and
process. However, as illustrated in (d ), the neurons were
host and not donor NSC-derived. (d ) The neurons were
host and not donor NSC-derived. The murine NSCs were
identified with M2, a mouse-specific marker that works
reliably in the rat host stem cell. The mNSCs were neither
NF (i) nor even GFAP, the latter finding suggesting that
they did not contribute to the glial scar. In fact, glial
scarring was diminished in ‘NSCscaffold’ stem cells (iv)
compared with ‘lesion control’ stem cells (v) based on
GFAP immunoreactivity. Most mNSCs remained
undifferentiated nestin cells (ii). (e) ‘ScaffoldNSC’
implantation significantly increased the presence of GAP-
43 fibres relative to other controls, a marker for
regenerating neurites. After administration of BDA for
antegrade tracing, BDA axons (not shown, but see Teng et
al. (2002)) were coursed through the lesion epicentre (as in
(c)) to reach areas caudal to the lesion in the scaffold-
containing groups. This suggests an anatomical substrate for
the functional improvement seen in those animals (a mean
of 14 on the 21-point BBB scale).
NSCs. Key to that model was the preliminary observation
that NSCs that have become neuronally committed
(seemingly their default differentiation pathway), appear to
actively promote the non-neuronal differentiation of their
equipotent sister cells via a membrane-associated mech-
anism. Briefly, within a clone of equipotent sister NSCs,
when the first cell exits the cell cycle and commits to a
neuronal phenotype (either stochastically, by default, or by
instruction) it then actively inhibits the neuronal differen-
tiation of its equipotent sister cells that subsequently exit
the cell cycle (even under conditions that would ordinarily
propel them towards a neuronal lineage). It effects this inhi-
bition, we believe, via membrane-associated factors that
exert their influence by direct cell–cell contact. Interest-
ingly, these factors appear to be independent of notch-delta
or bone morphogenic protein signalling. Membranes from
sister cells that differ only in that they have not made such
a neuronal commitment do not have this effect.
Such an autonomous self-assembly developmental
scheme establishes a network independent of external
instruction wherein a neuron is always flanked by non-
neurons (often astroglia). One can envision the primitive
fabric of the brain being spontaneously woven based on
this scheme starting with a few multipotent NSCs. A poss-
ible biological ‘rationale’ for the existence of such a devel-
opmental ‘program’ is provided by taking into account our
recent observations (described previously) of GDNF
peptide and receptor expression by various differentiation
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states of the same NSC. The non-neurons are forced to
be ‘chaperones’ for, and by, their sibling neuron, provid-
ing the trophic support needed by the neuron. Such a
developmental scheme for NSC-mediated CNS self-
assembly, cell-type determination, and ‘division of
labour’, based on intercellular communication between
members of a single NSC clone ensures that each neuron
is surrounded by cells that can vouchsafe its survival.
Although GDNF may be ‘intended’ by non-neuronal
‘chaperones’ for support of their juxtaposed neuronal
clonal members, this factor probably has a broader sphere
of influence, including support and/or neuroprotection of
‘bystander’ host neurons. In other words, when one trans-
plants NSCs into a diseased recipient, host cells, as
‘bystanders’ of this developmental program, become the
indirect beneficiaries of this trophic factor production.
It is also significant to realize that the GDNF is not
produced by the NSCs tonically, but seems to be released
in a sporadic pulsatile manner. In attempting to dissect the
signal transduction pathway mediating GDNF expression
and the type of production observed, inhibitors of either
the MAP kinase kinase pathway were employed versus
inhibitors of the PI3 kinase pathway; the former pathway
broadly subserving more permanent changes in neural
progenitors (e.g. differentiation, apoptosis, etc.), the latter
pathway subserving responses that are more transient
adjustments to environmental influences (e.g. prolifer-
ation, stress, etc.). Such preliminary experiments sug-
gested that it was the PI3 kinase pathway that mediated
the GDNF response. Nitric oxide donor molecules, simu-
lating environmental stress, increased GDNF expression.
Such evidence that GDNF (presumably representative
of other neurotrophic agents) is expressed in a regulated,
stimulus-appropriate, region- and cell-type-specific man-
ner supports a view that NSCs may serve as better gene
delivery vehicles than non-neural cells or non-cellular vec-
tors because the production of neural-relevant gene pro-
ducts by NSCs is part of their fundamental biology. This
point was reinforced in a recent experiment (Himes et al.
2001) in which the ability of NT-3 to rescue neurons in
Clarke’s nucleus after axotomy was explored. Rescue was
found to be greater when NT-3 was delivered from
engrafted NT-3-expressing NSCs than by administering
the peptide alone. The suggestion was that the NSCs
might provide additional factors or provide more physio-
logical regulated concentrations of the factors, or act as
a target or bridge that supports regenerating axons. This
observation gets to the heart of some of the advantages of
NSCs—whether unmanipulated or genetically engine-
ered—in CNS dysfunction. We believe that trophic sup-
port is best supplied by cellular vehicles of neural origin,
specifically NSCs, because, as suggested above, these mol-
ecules can be released in a regulated fashion, targeted in
a site-specific manner from members of the parenchyma,
with less concern for transgene downregulation (given
their intrinsic basal expression by the NSC) while simul-
taneously providing the possibility of cellular replacement.
Whether one chooses to use transplanted NSCs or
attempts to manipulate endogenous NSCs, an understand-
ing of the reciprocal interactions between genes and NSC
biology, between differentiation state and gene expression,
and between injured host and NSC, will be critical. Their
use must be dictated by a greater knowledge of NSC biology
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and of how various neurotrophic agents interact within the
NSC and with the degenerating host environment. Isolated,
well-characterized, homogenous clones of NSCs may make
such study more easily observed and controlled.
10. A ‘PROGRAM’ MAY CALL FOR NSCs TO
MEDIATE THE INTEGRATION AND
COORDINATION OF NEURAL WITH
NON-NEURAL SYSTEMS
Although we, as scientists, need to focus upon one cell
type or one organ system to design interpretable experi-
ments, it should never escape our notice that a given struc-
ture in the body is actually not composed simply of one
system isolated from the others. For an appendage or an
organ to grow, multiple developmental processes, neuro-
genesis, osteogenesis, angiogenesis, myogenesis, chondrog-
enesis, etc., must all be intimately coordinated, presumably
by a network of constant reciprocal cross-talk between pro-
genitors of the various systems. Furthermore, from the van-
tage point of a neurobiologist, it is instructive to realize that
ultimately every organ is innervated (often by the auto-
nomic, enteric and peripheral nervous systems): every
blood vessel, every sweat gland, every sphincter, every
bone, and could probably not function without that neural
component. An interesting series of pilot experiments has
hinted at the pivotal role the nervous system, and the NSC
as its effector, may play in initiating, catalysing, directing
and synchronizing the assembly of some of these organs,
exemplified by the neuromusculo-skeletal-vascular unit.
Another ‘Macro-Program’ may be suggested.
In the first pilot experiments, rat myoblasts and murine
NSCs were mixed in a collagen solution and injected sub-
cutaneously in a nude mouse. Although each cell type
injected alone failed to flourish and died, in combination,
the cells began to self-organize into a mass that resembled
muscle tissue. Moreover, this subcutaneous ‘muscle’
began to attract innervation from the intercostal nerves
and vascularization from the intercostal arteries of the
adjoining thoracic segment. Ultimately, a mature capillary
network permeated the new muscle. The presence of bona
fide muscle tissue was confirmed by immunostaining for
myosin heavy chain. The mature myofibrils, it is crucial
to emphasize, derived from the implanted rat myoblasts;
they did not result from transdifferentiation of the murine
NSCs. (The species differences between the two progeni-
tor populations ensured that proper lineage could be
assigned.) Organized muscle bundles were, however, sur-
rounded by undifferentiated NSCs.
In the next pilot experiments, this paradigm was
extended to a more physiologically relevant context to
observe whether NSCs could, indeed, promote skeletal
muscle regeneration by catalysing the creation of a func-
tional muscle in situ and guide its local innervation and
vascularization. The tibialis anterior muscle was entirely
removed from a nude mouse. A combination of murine
NSCs and rat myoblasts (supported by biological matrix,
bladder submucosa) was implanted into the empty muscle
bed. After three weeks, once again, the implanted cells
began to self-assemble into a coherent mass. Mature mus-
cular bundles coursed throughout the new tissue and NSCs
had distributed themselves evenly throughout. New vessels
penetrated the mass. Importantly, a branch of the sciatic
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nerve could be seen coursing towards and entering the new
muscle. Again, the new myofibrils were derived from the
myoblasts, not from the NSCs; there was no transdifferen-
tiation. Interestingly, the NSCs also did not differentiate
into neurons. Rather they interacted with the regenerating
sciatic nerve endings, guiding them to the acetylcholine
receptors on the new muscle. When the sciatic nerve was
electrically stimulated, the new mass contracted appropri-
ately, a contraction that could be measured electrically and
recorded. The creation of a contractile organ reactive to
electrical stimulation emerged only when both NSCs and
myoblasts were intermixed; samples containing no cells, or
bladder submucosa alone, or solely NSCs or solely myo-
blasts produced no contractile structure.
In summary we, and others, have spent a good deal of
effort demonstrating that NSCs interact with their neural
environment. For the first time, however, we have begun
to observe an additional set of programs that make
immense sense for a more global view of organogenesis:
that NSCs interact with and help promote the develop-
ment of other systems with which they are in intimate con-
tact; for example, muscle, vasculature, skin, etc. In these
preliminary experiments, NSCs acted on local non-neural
progenitors to create an innervated, functional contractile
structure assimilated appropriately in vivo. The NSC may
prove to be a useful tool for dissecting the developmental
processes by which a functional organ emerges from the
interactions between seemingly disparate components. In
acquiring a better understanding of this process, we may
also gain an insight into how to use NSCs for promoting
the repair and regeneration of even non-neural systems.
11. CLOSING THOUGHTS
In summary, NSCs are not only able to mediate cell
replacement and gene therapy, but also to perform other
intriguing functions as a result of their fundamental biology
and the role they play in some complex developmental pro-
grams. For example, transplanted NSCs trigger and/or aug-
ment constitutive reparative responses by facilitating a
series of reciprocal interactions between themselves and
host CNS tissue (both injured and intact) including:
(i) promoting neuronal differentiation;
(ii) enhancing ingrowth/outgrowth of neural processes;
(iii) fostering reformation of neural tissue;
(iv) promoting connectivity after injury;
(v) promoting preservation of parenchyma;
(vi) reducing secondary injury processes;
(vii) reducing inflammation/scarring (facilitating recon-
stitution);
(viii) coordinating interaction among other somatic systems.
The study of NSCs by neurobiologists over almost the
past two decades has helped stimulate investigators of
other organ systems to search for ‘stem-like’ cells even
within tissues generally held to be more regenerative, more
forgiving and/or more redundant than the CNS. The
results have been rewarding indeed. Hence, the NSC—in
effect the first ‘solid organ stem cell’ isolated and
exploited—served, and continues to serve, as a model for
other somatic stem cells. Importantly, despite the spotlight
of therapeutic promise the NSC has thrown upon itself
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(and other stem cells), it is critical to remember that its
existence was unveiled in the course of understanding
development and that, in the end, the stem cell is simply
one player in a broad and exceedingly complex, interde-
pendent, finely tuned developmental system; one that
requires fundamental developmental understanding. In
this endeavour, the CNS continues to serve as an instruc-
tive model for the stem cell field in general.
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GLOSSARY
BBB: Basso–Bresnahan–Beatie
BDA: biotinylated dextran amine
BDNF: brain-derived neurotrophic factor
BrdU: bromodeoxyuridine
CNPase: 23-cyclic nucleotide-3-phosphodiesterase
CNS: central nervous system
DA: dopaminergic
DAT: dopamine transporter
GDNF: glial-cell-line-derived neurotrophic factor
H&E: haematoxylin and eosin
HI: hypoxic–ischaemic
hNSC: human neural stem cell
MPTP: methyl-4-phenyl-1,2,3,6-tetrahydropyridine
NF: neurofilament
NGF: nerve growth factor
NSC: neural stem cell
NT-3: neurotrophin-3
OB: olfactory bulb
PGA: polyglycolic acid
RMS: rostral migratory stream
SN: substantia nigra
SVZa: anterior subventricular zone
TH: tyrosine hydroxylase
VTA: ventral tegmental area
